Autres langues Zhuhai Rundu Pharmaceutical Co., Ltd.

Actions

002923

CNE1000033G8

Produits pharmaceutiques

Cours en clôture Shenzhen S.E. Autres places de cotation 24/07/2026			Varia. 5j.	Varia. 1 janv.
10,12 ^CNY	-4,08 %		-4,98 %	-16,71 %

22/05	Zhuhai Rundu Pharmaceutical obtient le feu vert en Chine pour un traitement contre la douleur	MT
19/05	Chine : Zhuhai Rundu Pharmaceutical obtient le feu vert pour la commercialisation d'un traitement contre l'hypertension	MT

Autres langues

22/05	Zhuhai Rundu Pharmaceutical Wins China Approval for Pain Relief Drug
19/05	China Grants Zhuhai Rundu Pharmaceutical Marketing Approval for Hypertension Drug
07/05	Zhuhai Rundu says key shareholder plans to unload up to 3% stake
06/05	Zhuhai Rundu Pharmaceutical's shareholder plans to unload shares
06/05	Rundu Pharmaceutical Gets Nod to Market Losartan Potassium
27/04	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026
07/04	Zhuhai Rundu Pharmaceutical Gets China Approval for Cardiac Stress Testing Drug
06/03	Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Election of Hu Zhengxi as Independent Director
25/02	Rundu Pharmaceutical Gets Registration Certificate for Ibuprofen Tablets
13/02	China Selects 12 Zhuhai Rundu Pharmaceutical Products for National Procurement Program
21/01	Rundu Pharmaceutical Gets Nod for Marketing of Sacubitril/Valsartan Sodium
14/12	Zhuhai Rundu Pharmaceutical's shareholders plan to cut stakes
31/10/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025
17/10/25	Rundu Pharmaceutical Gets China Marketing Nod for Chest Pain Tablets
26/09/25	Zhuhai Rundu Pharmaceutical Gets China Supplementary Nod for Herpes Drug
29/08/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025
13/08/25	Zhuhai Rundu Pharmaceutical Gets Marketing Approval for Osteoarthritis API
05/08/25	Zhuhai Rundu Pharmaceutical Gets Approval for Muscle Relaxant
20/07/25	Rundu Pharma's shareholder to unload up to 3% stake in co
04/07/25	Rundu Pharmaceutical Gets Registration Certificate for Moxifloxacin Hydrochloride Tablets
30/06/25	Zhuhai Rundu Pharmaceutical Passes Brazilian GMP Certification for Four APIs
27/06/25	Zhuhai Rundu Pharmaceutical Passes US FDA On-Site Manufacturing Practice Inspection
21/05/25	Zhuhai Rundu Pharmaceutical Co., Ltd. Approves Final Cash Dividend on A Shares for 2024, Payable on 30 May 2025
14/05/25	Rundu Pharmaceutical Gets Regulatory Approval for Veterinary Antibiotic
13/05/25	Rundu Pharmaceutical Gets Drug Registration for Isosorbide Mononitrate Tablets